SPY433.74-8.90 -2.01%
DIA343.10-5.51 -1.58%
IXIC14,578.14-391.83 -2.62%

KeyBanc Adjusts Quest Diagnostics' Price Target to $168 from $144, Keeps Overweight Rating

MT Newswires · 09/01/2021 05:04

Please log in to view news